| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.683 | 0.005 | 0.683 | Cardiotonic | 0.683 0.005 DBMET03419 0.358 0.037 DBMET03420 0.642 0.005 DBMET03424 0.32 0.048 DBMET03421 0.592 0.008 DBMET03425 | ||
| 0.568 | 0.002 | 0.568 | Endothelin receptor antagonist | 0.568 0.002 DBMET03419 0.412 0.003 DBMET03420 0.446 0.002 DBMET03424 0.37 0.003 DBMET03421 0.42 0.002 DBMET03425 0.151 0.004 DBMET03426 | ||
| 0.541 | 0.002 | 0.541 | Endothelin A receptor antagonist | 0.541 0.002 DBMET03419 0.358 0.002 DBMET03420 0.399 0.002 DBMET03424 0.331 0.003 DBMET03421 0.37 0.002 DBMET03425 0.113 0.004 DBMET03426 | ||
| 0.432 | 0.004 | 0.464 | Raf kinase C inhibitor | 0.432 0.004 DBMET03419 0.086 0.03 DBMET03420 0.464 0.004 DBMET03424 0.057 0.044 DBMET03421 0.356 0.004 DBMET03425 | DBMET03424 | |
| 0.271 | 0.003 | 0.271 | Endothelin B receptor antagonist | 0.271 0.003 DBMET03419 0.149 0.004 DBMET03420 0.172 0.003 DBMET03424 0.12 0.004 DBMET03421 0.16 0.003 DBMET03425 0.04 0.007 DBMET03426 | ||
| 0.23 | 0.019 | 0.387 | MAP kinase kinase inhibitor | 0.23 0.019 DBMET03419 0.17 0.041 DBMET03420 0.387 0.004 DBMET03424 0.153 0.049 DBMET03425 0.1 0.095 DBMET03426 | DBMET03424 | |
| 0.24 | 0.057 | 0.422 | ErbB-1 antagonist | 0.24 0.057 DBMET03419 0.422 0.014 DBMET03420 0.285 0.037 DBMET03424 0.226 0.066 DBMET03425 0.401 0.016 DBMET03426 | DBMET03420 | |
| 0.189 | 0.02 | 0.192 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.189 0.02 DBMET03419 0.09 0.062 DBMET03420 0.192 0.019 DBMET03424 0.105 0.05 DBMET03425 | DBMET03424 | |
| 0.258 | 0.101 | 0.258 | Nootropic | 0.258 0.101 DBMET03419 | ||
| 0.156 | 0.014 | 0.223 | MAP kinase kinase 1 inhibitor | 0.156 0.014 DBMET03419 0.141 0.02 DBMET03420 0.223 0.004 DBMET03424 0.122 0.033 DBMET03425 0.111 0.045 DBMET03426 | DBMET03424 | |
| 0.154 | 0.018 | 0.154 | Raf kinase inhibitor | 0.154 0.018 DBMET03419 0.152 0.019 DBMET03424 0.077 0.048 DBMET03425 | ||
| 0.161 | 0.039 | 0.263 | Aurora-C kinase inhibitor | 0.161 0.039 DBMET03419 0.263 0.008 DBMET03420 0.121 0.103 DBMET03421 0.121 0.105 DBMET03426 | DBMET03420 | |
| 0.139 | 0.035 | 0.142 | Nav1.5 sodium channel blocker | 0.139 0.035 DBMET03419 0.142 0.032 DBMET03420 | DBMET03420 | |
| 0.147 | 0.05 | 0.275 | Epidermal growth factor receptor kinase inhibitor | 0.147 0.05 DBMET03419 0.275 0.011 DBMET03420 0.174 0.035 DBMET03424 0.13 0.063 DBMET03425 0.249 0.015 DBMET03426 | DBMET03420 | |
| 0.152 | 0.057 | 0.152 | Sodium channel blocker | 0.152 0.057 DBMET03419 0.142 0.063 DBMET03424 | ||
| 0.096 | 0.061 | 0.171 | Interleukin 12 antagonist | 0.096 0.061 DBMET03419 0.171 0.008 DBMET03420 0.092 0.068 DBMET03421 | DBMET03420 | |
| 0.064 | 0.03 | 0.08 | Bcl-xL inhibitor | 0.064 0.03 DBMET03419 0.075 0.015 DBMET03424 0.08 0.012 DBMET03425 | DBMET03425 | |
| 0.073 | 0.045 | 0.073 | ZAP-70 protein tyrosine kinase inhibitor | 0.073 0.045 DBMET03419 0.073 0.044 DBMET03420 0.071 0.047 DBMET03424 | ||
| 0.073 | 0.047 | 0.086 | Phosphodiesterase 5A inhibitor | 0.073 0.047 DBMET03419 0.086 0.035 DBMET03420 | DBMET03420 | |
| 0.069 | 0.053 | 0.082 | Phosphodiesterase V inhibitor | 0.069 0.053 DBMET03419 0.082 0.039 DBMET03420 | DBMET03420 | |
| 0.206 | 0.201 | 0.206 | Antiobesity | 0.206 0.201 DBMET03419 | ||
| 0.044 | 0.044 | 0.05 | Neuropeptide Y5 antagonist | 0.05 0.037 DBMET03424 | DBMET03424 | |
| 0.098 | 0.101 | 0.124 | Interleukin 8 antagonist | 0.124 0.056 DBMET03420 0.114 0.07 DBMET03426 | DBMET03420 | |
| 0.104 | 0.11 | 0.171 | Interleukin 4 antagonist | 0.171 0.034 DBMET03420 | DBMET03420 | |
| 0.068 | 0.088 | 0.245 | Epidermal growth factor antagonist | 0.245 0.01 DBMET03420 0.077 0.071 DBMET03424 0.203 0.014 DBMET03426 | DBMET03420 | |
| 0.084 | 0.107 | 0.173 | DNA polymerase I inhibitor | 0.173 0.038 DBMET03420 0.145 0.052 DBMET03421 0.131 0.06 DBMET03426 | DBMET03420 | |
| 0.096 | 0.12 | 0.435 | Growth factor antagonist | 0.435 0.015 DBMET03420 0.177 0.055 DBMET03426 | DBMET03420 | |
| 0.025 | 0.052 | 0.039 | AMPA receptor agonist | 0.034 0.026 DBMET03424 0.039 0.019 DBMET03425 | DBMET03425 | |
| 0.009 | 0.038 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.011 DBMET03420 | DBMET03420 | |
| 0.122 | 0.155 | 0.277 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.277 0.049 DBMET03420 0.154 0.109 DBMET03426 | DBMET03420 | |
| 0.025 | 0.058 | 0.042 | Secretase gamma inhibitor | 0.042 0.03 DBMET03424 | DBMET03424 | |
| 0.084 | 0.119 | 0.215 | Nav1.3 sodium channel blocker | 0.215 0.02 DBMET03424 0.135 0.059 DBMET03425 | DBMET03424 | |
| 0.067 | 0.108 | 0.138 | Aminoacyl-tRNA synthetase inhibitor | 0.094 0.052 DBMET03420 0.109 0.037 DBMET03424 0.092 0.055 DBMET03425 0.138 0.023 DBMET03426 | DBMET03426 | |
| 0.05 | 0.098 | 0.215 | MAP3K7 inhibitor | 0.208 0.006 DBMET03420 0.215 0.005 DBMET03426 | DBMET03426 | |
| 0.039 | 0.089 | 0.049 | Vanilloid 2 antagonist | 0.049 0.045 DBMET03424 | DBMET03424 | |
| 0.022 | 0.093 | 0.048 | Somatostatin 4 agonist | 0.048 0.016 DBMET03420 | DBMET03420 | |
| 0.019 | 0.106 | 0.06 | Carbonic anhydrase I inhibitor | 0.054 0.04 DBMET03424 0.06 0.035 DBMET03421 | DBMET03421 | |
| 0.021 | 0.119 | 0.077 | Carbonic anhydrase inhibitor | 0.073 0.038 DBMET03424 0.077 0.036 DBMET03421 | DBMET03421 | |
| 0.051 | 0.153 | 0.127 | Hepatocyte growth factor antagonist | 0.127 0.032 DBMET03420 | DBMET03420 | |
| 0.017 | 0.132 | 0.043 | Purinergic P2X3 antagonist | 0.043 0.014 DBMET03420 0.034 0.024 DBMET03426 | DBMET03420 | |
| 0.077 | 0.195 | 0.174 | Mcl-1 antagonist | 0.135 0.106 DBMET03424 0.174 0.071 DBMET03425 0.132 0.11 DBMET03426 | DBMET03425 | |
| 0.004 | 0.126 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.008 DBMET03425 | DBMET03425 | |
| 0.009 | 0.135 | 0.067 | Carbonic anhydrase XII inhibitor | 0.067 0.03 DBMET03421 | DBMET03421 | |
| 0.134 | 0.268 | 0.431 | Immunomodulator | 0.431 0.036 DBMET03420 0.21 0.152 DBMET03426 | DBMET03420 | |
| 0.008 | 0.143 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET03424 0.024 0.012 DBMET03426 | DBMET03426 | |
| 0.046 | 0.189 | 0.346 | Vascular endothelial growth factor antagonist | 0.346 0.017 DBMET03420 0.147 0.055 DBMET03426 | DBMET03420 | |
| 0.059 | 0.204 | 0.276 | Tyrosine kinase inhibitor | 0.276 0.048 DBMET03420 | DBMET03420 | |
| 0.004 | 0.151 | 0.04 | Prostacyclin agonist | 0.023 0.007 DBMET03425 0.04 0.005 DBMET03426 | DBMET03426 | |
| 0.036 | 0.184 | 0.334 | Vascular endothelial growth factor 2 antagonist | 0.334 0.017 DBMET03420 0.129 0.057 DBMET03426 | DBMET03420 | |
| 0.031 | 0.19 | 0.12 | ErbB-2 antagonist | 0.12 0.027 DBMET03420 0.103 0.034 DBMET03426 | DBMET03420 | |
| 0.018 | 0.18 | 0.057 | Phosphatidylinositol 3-kinase beta inhibitor | 0.057 0.027 DBMET03420 | DBMET03420 | |
| 0.04 | 0.205 | 0.133 | ErbB-3 antagonist | 0.108 0.036 DBMET03420 0.133 0.024 DBMET03426 | DBMET03426 | |
| 0.026 | 0.197 | 0.188 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.188 0.006 DBMET03420 0.174 0.008 DBMET03426 | DBMET03420 | |
| 0.06 | 0.231 | 0.241 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.241 0.027 DBMET03420 | DBMET03420 | |
| 0.041 | 0.215 | 0.36 | Protein-tyrosine kinase Lyn inhibitor | 0.36 0.01 DBMET03420 0.257 0.028 DBMET03426 | DBMET03420 | |
| 0.033 | 0.209 | 0.143 | MAP kinase kinase kinase inhibitor | 0.121 0.05 DBMET03420 0.143 0.039 DBMET03426 | DBMET03426 | |
| 0.032 | 0.214 | 0.066 | Interferon inducer | 0.066 0.041 DBMET03420 0.059 0.056 DBMET03426 | DBMET03420 | |
| 0.024 | 0.206 | 0.07 | Thromboxane synthase inhibitor | 0.07 0.018 DBMET03425 | DBMET03425 | |
| 0.02 | 0.211 | 0.054 | Phosphatidylinositol kinase inhibitor | 0.054 0.049 DBMET03420 | DBMET03420 | |
| 0.023 | 0.218 | 0.117 | ErbB-4 antagonist | 0.117 0.032 DBMET03420 0.068 0.062 DBMET03426 | DBMET03420 | |
| 0.006 | 0.202 | 0.078 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.078 0.005 DBMET03420 0.077 0.005 DBMET03426 | DBMET03420 | |
| 0.026 | 0.228 | 0.096 | Fibroblast growth factor 1 antagonist | 0.096 0.061 DBMET03420 | DBMET03420 | |
| 0.031 | 0.233 | 0.082 | Interferon agonist | 0.082 0.049 DBMET03420 0.077 0.057 DBMET03426 | DBMET03420 | |
| 0.025 | 0.232 | 0.236 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.236 0.029 DBMET03420 0.096 0.082 DBMET03426 | DBMET03420 | |
| 0.024 | 0.235 | 0.168 | TIE-2 antagonist | 0.168 0.019 DBMET03420 0.103 0.038 DBMET03426 | DBMET03420 | |
| 0.037 | 0.251 | 0.175 | EphA2 antagonist | 0.175 0.02 DBMET03420 0.168 0.023 DBMET03426 | DBMET03420 | |
| 0.023 | 0.242 | 0.169 | TIE antagonist | 0.169 0.019 DBMET03420 0.103 0.039 DBMET03426 | DBMET03420 | |
| 0.027 | 0.247 | 0.131 | Platelet activating factor alpha antagonist | 0.131 0.038 DBMET03420 | DBMET03420 | |
| 0.032 | 0.255 | 0.328 | RET inhibitor | 0.328 0.018 DBMET03420 0.223 0.037 DBMET03426 | DBMET03420 | |
| 0.142 | 0.37 | 0.2 | MAP kinase kinase 3 inhibitor | 0.2 0.121 DBMET03420 0.192 0.148 DBMET03426 | DBMET03420 | |
| 0.021 | 0.249 | 0.122 | Platelet activating factor beta antagonist | 0.122 0.049 DBMET03420 | DBMET03420 | |
| 0.011 | 0.239 | 0.099 | Phosphatidylinositol 3-kinase delta inhibitor | 0.099 0.02 DBMET03420 0.068 0.031 DBMET03426 | DBMET03420 | |
| 0.032 | 0.261 | 0.085 | MAP kinase 8 inhibitor | 0.085 0.081 DBMET03420 | DBMET03420 | |
| 0.004 | 0.234 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 DBMET03426 | DBMET03426 | |
| 0.076 | 0.312 | 0.409 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.409 0.013 DBMET03420 0.337 0.028 DBMET03426 | DBMET03420 | |
| 0.025 | 0.267 | 0.113 | Protein kinase B alpha inhibitor | 0.113 0.022 DBMET03420 0.073 0.045 DBMET03426 | DBMET03420 | |
| 0.032 | 0.283 | 0.244 | Vascular endothelial growth factor 3 antagonist | 0.244 0.028 DBMET03420 0.152 0.065 DBMET03426 | DBMET03420 | |
| 0.025 | 0.277 | 0.199 | c-Src kinase inhibitor | 0.199 0.035 DBMET03420 0.193 0.037 DBMET03426 | DBMET03420 | |
| 0.083 | 0.339 | 0.221 | Hypoglycemic | 0.167 0.152 DBMET03424 0.221 0.095 DBMET03425 | DBMET03425 | |
| 0.035 | 0.294 | 0.232 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.232 0.041 DBMET03420 0.17 0.065 DBMET03426 | DBMET03420 | |
| 0.048 | 0.309 | 0.307 | LIM domain kinase 1 inhibitor | 0.307 0.019 DBMET03420 0.255 0.035 DBMET03426 | DBMET03420 | |
| 0.01 | 0.271 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 DBMET03425 | DBMET03425 | |
| 0.005 | 0.268 | 0.028 | HCV NS5B polymerase inhibitor | 0.028 0.026 DBMET03425 | DBMET03425 | |
| 0.04 | 0.304 | 0.233 | Src kinase inhibitor | 0.233 0.041 DBMET03420 0.202 0.053 DBMET03426 | DBMET03420 | |
| 0.039 | 0.306 | 0.28 | CDC-like kinase 4 inhibitor | 0.28 0.037 DBMET03420 0.167 0.088 DBMET03426 | DBMET03420 | |
| 0.099 | 0.367 | 0.461 | RNA-directed DNA polymerase inhibitor | 0.325 0.027 DBMET03420 0.165 0.162 DBMET03425 0.461 0.013 DBMET03426 | DBMET03426 | |
| 0.037 | 0.308 | 0.316 | Clk dual-specificity kinase inhibitor | 0.316 0.035 DBMET03420 0.234 0.062 DBMET03426 | DBMET03420 | |
| 0.039 | 0.31 | 0.272 | Protein kinase C nu inhibitor | 0.272 0.03 DBMET03420 0.139 0.076 DBMET03426 | DBMET03420 | |
| 0.018 | 0.291 | 0.194 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.194 0.023 DBMET03420 | DBMET03420 | |
| 0.134 | 0.409 | 0.264 | MAP kinase 1 inhibitor | 0.264 0.218 DBMET03420 | DBMET03420 | |
| 0.006 | 0.282 | 0.055 | Fructose-1,6-bisphosphatase inhibitor | 0.055 0.021 DBMET03426 | DBMET03426 | |
| 0.019 | 0.303 | 0.078 | Stem cell growth factor agonist | 0.078 0.068 DBMET03420 | DBMET03420 | |
| 0.051 | 0.338 | 0.34 | MAP kinase kinase 2 inhibitor | 0.34 0.023 DBMET03420 0.221 0.069 DBMET03426 | DBMET03420 | |
| 0.059 | 0.351 | 0.178 | Polo-like kinase-3 inhibitor | 0.178 0.059 DBMET03420 | DBMET03420 | |
| 0.06 | 0.354 | 0.144 | Insulin secretagoues | 0.123 0.106 DBMET03424 0.144 0.08 DBMET03425 | DBMET03425 | |
| 0.005 | 0.301 | 0.1 | Prostacyclin antagonist | 0.055 0.011 DBMET03425 0.1 0.005 DBMET03426 | DBMET03426 | |
| 0.056 | 0.355 | 0.462 | Platelet aggregation inhibitor | 0.142 0.139 DBMET03420 0.221 0.067 DBMET03425 0.462 0.012 DBMET03426 | DBMET03426 | |
| 0.048 | 0.35 | 0.182 | Interleukin antagonist | 0.182 0.095 DBMET03420 | DBMET03420 | |
| 0.021 | 0.326 | 0.099 | Platelet activating factor antagonist | 0.099 0.08 DBMET03420 | DBMET03420 | |
| 0.078 | 0.389 | 0.441 | Angiogenesis inhibitor | 0.441 0.042 DBMET03420 0.366 0.064 DBMET03426 | DBMET03420 | |
| 0.024 | 0.336 | 0.088 | AXL receptor tyrosine kinase inhibitor | 0.088 0.05 DBMET03420 | DBMET03420 | |
| 0.026 | 0.339 | 0.181 | Ephrin antagonist | 0.181 0.029 DBMET03420 0.136 0.042 DBMET03426 | DBMET03420 | |
| 0.021 | 0.334 | 0.063 | Glutamate (mGluR group I) antagonist | 0.063 0.06 DBMET03420 | DBMET03420 | |
| 0.043 | 0.361 | 0.324 | TRKC antagonist | 0.324 0.02 DBMET03420 0.246 0.049 DBMET03426 | DBMET03420 | |
| 0.003 | 0.324 | 0.04 | Adenosine kinase inhibitor | 0.032 0.009 DBMET03420 0.04 0.007 DBMET03426 | DBMET03426 | |
| 0.035 | 0.358 | 0.298 | Protein kinase (CK1) gamma 1 inhibitor | 0.298 0.02 DBMET03420 0.237 0.032 DBMET03426 | DBMET03420 | |
| 0.008 | 0.34 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.014 DBMET03420 0.026 0.019 DBMET03426 | DBMET03420 | |
| 0.073 | 0.406 | 0.285 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.285 0.033 DBMET03420 0.245 0.045 DBMET03426 | DBMET03420 | |
| 0.005 | 0.343 | 0.044 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.044 0.038 DBMET03420 | DBMET03420 | |
| 0.022 | 0.362 | 0.054 | Antiviral (Hepatitis D) | 0.054 0.029 DBMET03426 | DBMET03426 | |
| 0.021 | 0.363 | 0.195 | Lck kinase inhibitor | 0.195 0.043 DBMET03420 0.164 0.057 DBMET03426 | DBMET03420 | |
| 0.024 | 0.366 | 0.283 | Protein kinase (CK1) gamma inhibitor | 0.283 0.021 DBMET03420 0.178 0.053 DBMET03426 | DBMET03420 | |
| 0.026 | 0.369 | 0.248 | CDC-like kinase 2 inhibitor | 0.248 0.046 DBMET03420 0.193 0.07 DBMET03426 | DBMET03420 | |
| 0.02 | 0.365 | 0.175 | Abl kinase inhibitor | 0.175 0.036 DBMET03420 0.106 0.081 DBMET03426 | DBMET03420 | |
| 0.02 | 0.365 | 0.175 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.175 0.036 DBMET03420 0.106 0.081 DBMET03426 | DBMET03420 | |
| 0.022 | 0.372 | 0.139 | Polo-like kinase-4 inhibitor | 0.139 0.043 DBMET03420 0.103 0.074 DBMET03426 | DBMET03420 | |
| 0.049 | 0.399 | 0.337 | DNA methylase inhibitor | 0.151 0.117 DBMET03420 0.136 0.131 DBMET03425 0.337 0.019 DBMET03426 | DBMET03426 | |
| 0.007 | 0.358 | 0.063 | Prostaglandin antagonist | 0.063 0.03 DBMET03425 0.058 0.033 DBMET03426 | DBMET03425 | |
| 0.021 | 0.374 | 0.125 | Vascular endothelial growth factor 1 antagonist | 0.125 0.052 DBMET03420 | DBMET03420 | |
| 0.013 | 0.366 | 0.045 | Thymidine kinase inhibitor | 0.045 0.023 DBMET03420 0.037 0.035 DBMET03426 | DBMET03420 | |
| 0.03 | 0.383 | 0.285 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.285 0.031 DBMET03420 0.244 0.048 DBMET03426 | DBMET03420 | |
| 0.018 | 0.373 | 0.067 | Glutamate (mGluR) antagonist | 0.067 0.065 DBMET03420 | DBMET03420 | |
| 0.048 | 0.412 | 0.161 | Vasodilator | 0.161 0.142 DBMET03426 | DBMET03426 | |
| 0.018 | 0.386 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET03420 | DBMET03420 | |
| 0.127 | 0.498 | 0.241 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.241 0.078 DBMET03420 0.24 0.079 DBMET03426 | DBMET03420 | |
| 0.021 | 0.395 | 0.139 | TRKB antagonist | 0.139 0.054 DBMET03420 | DBMET03420 | |
| 0.013 | 0.387 | 0.062 | Purinergic P2X2 antagonist | 0.062 0.05 DBMET03426 | DBMET03426 | |
| 0.045 | 0.42 | 0.324 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.324 0.03 DBMET03420 0.281 0.041 DBMET03426 | DBMET03420 | |
| 0.075 | 0.456 | 0.429 | Vasodilator, peripheral | 0.322 0.086 DBMET03420 0.429 0.047 DBMET03426 | DBMET03426 | |
| 0.008 | 0.394 | 0.051 | DNA-dependent protein kinase inhibitor | 0.051 0.021 DBMET03420 0.04 0.029 DBMET03426 | DBMET03420 | |
| 0.041 | 0.427 | 0.264 | Adenylate kinase inhibitor | 0.107 0.057 DBMET03420 0.264 0.009 DBMET03426 | DBMET03426 | |
| 0.037 | 0.426 | 0.118 | Interleukin 1 antagonist | 0.118 0.092 DBMET03420 | DBMET03420 | |
| 0.002 | 0.398 | 0.045 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.045 0.01 DBMET03426 | DBMET03426 | |
| 0.033 | 0.444 | 0.176 | Immunostimulant | 0.157 0.149 DBMET03421 0.176 0.135 DBMET03426 | DBMET03426 | |
| 0.019 | 0.436 | 0.226 | Protein kinase (CK1) gamma 2 inhibitor | 0.226 0.025 DBMET03420 0.121 0.064 DBMET03426 | DBMET03420 | |
| 0.023 | 0.449 | 0.142 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.142 0.066 DBMET03420 | DBMET03420 | |
| 0.026 | 0.453 | 0.1 | MAP kinase 13 inhibitor | 0.1 0.081 DBMET03420 | DBMET03420 | |
| 0.022 | 0.454 | 0.317 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.317 0.032 DBMET03420 0.273 0.039 DBMET03426 | DBMET03420 | |
| 0.014 | 0.447 | 0.055 | Glutamate (mGluR4) antagonist | 0.055 0.016 DBMET03426 | DBMET03426 | |
| 0.019 | 0.453 | 0.291 | Dyrk kinase inhibitor | 0.291 0.056 DBMET03420 0.197 0.1 DBMET03426 | DBMET03420 | |
| 0.024 | 0.465 | 0.222 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.222 0.058 DBMET03420 0.167 0.083 DBMET03426 | DBMET03420 | |
| 0.009 | 0.452 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 DBMET03420 0.102 0.014 DBMET03426 | DBMET03426 | |
| 0.009 | 0.453 | 0.08 | Adenosine deaminase inhibitor | 0.05 0.031 DBMET03420 0.08 0.009 DBMET03426 | DBMET03426 | |
| 0.016 | 0.466 | 0.278 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.278 0.056 DBMET03420 0.191 0.098 DBMET03426 | DBMET03420 | |
| 0.003 | 0.455 | 0.041 | Antimetabolite | 0.041 0.04 DBMET03426 | DBMET03426 | |
| 0.067 | 0.528 | 0.214 | Sodium/bile acid cotransporter inhibitor | 0.214 0.17 DBMET03425 | DBMET03425 | |
| 0.006 | 0.469 | 0.11 | Acyl-CoA dehydrogenase inhibitor | 0.11 0.014 DBMET03426 | DBMET03426 | |
| 0.017 | 0.48 | 0.179 | Diuretic | 0.153 0.075 DBMET03425 0.179 0.054 DBMET03426 | DBMET03426 | |
| 0.016 | 0.48 | 0.146 | CDC-like kinase 1 inhibitor | 0.146 0.073 DBMET03426 | DBMET03426 | |
| 0.006 | 0.474 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET03426 | DBMET03426 | |
| 0.018 | 0.49 | 0.095 | Adenosine A3 receptor antagonist | 0.095 0.029 DBMET03426 | DBMET03426 | |
| 0.024 | 0.502 | 0.155 | Death-associated protein kinase 3 inhibitor | 0.155 0.115 DBMET03420 | DBMET03420 | |
| 0.009 | 0.489 | 0.116 | Insulin like growth factor 1 antagonist | 0.116 0.031 DBMET03420 | DBMET03420 | |
| 0.005 | 0.488 | 0.133 | Protein kinase (CK1) delta inhibitor | 0.133 0.064 DBMET03420 | DBMET03420 | |
| 0.057 | 0.541 | 0.148 | Growth factor agonist | 0.148 0.145 DBMET03420 | DBMET03420 | |
| 0.015 | 0.502 | 0.146 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.146 0.067 DBMET03420 | DBMET03420 | |
| 0.008 | 0.497 | 0.066 | CDC7 inhibitor | 0.066 0.049 DBMET03420 | DBMET03420 | |
| 0.008 | 0.5 | 0.124 | Insulin growth factor antagonist | 0.124 0.031 DBMET03420 | DBMET03420 | |
| 0.054 | 0.548 | 0.23 | Toll-Like receptor 7 agonist | 0.23 0.167 DBMET03420 | DBMET03420 | |
| 0.012 | 0.506 | 0.08 | Heat shock protein 90 beta antagonist | 0.08 0.021 DBMET03420 | DBMET03420 | |
| 0.007 | 0.501 | 0.077 | Leucine-rich repeat kinase 2 inhibitor | 0.077 0.061 DBMET03420 | DBMET03420 | |
| 0.053 | 0.55 | 0.228 | Toll-Like receptor agonist | 0.228 0.17 DBMET03420 | DBMET03420 | |
| 0.006 | 0.508 | 0.196 | Phosphofructokinase-1 inhibitor | 0.196 0.011 DBMET03426 | DBMET03426 | |
| 0.016 | 0.519 | 0.075 | Factor IXa inhibitor | 0.065 0.023 DBMET03420 0.049 0.039 DBMET03421 0.075 0.018 DBMET03426 | DBMET03426 | |
| 0.007 | 0.515 | 0.146 | Carbamoyl phosphate synthetase inhibitor | 0.146 0.012 DBMET03426 | DBMET03426 | |
| 0.016 | 0.524 | 0.179 | Ribosomal protein S6 kinase inhibitor | 0.179 0.047 DBMET03420 0.116 0.095 DBMET03426 | DBMET03420 | |
| 0.003 | 0.518 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 DBMET03426 | DBMET03426 | |
| 0.006 | 0.525 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.033 DBMET03426 | DBMET03426 | |
| 0.004 | 0.523 | 0.104 | Adenosine A2 receptor antagonist | 0.104 0.026 DBMET03420 0.077 0.036 DBMET03426 | DBMET03420 | |
| 0.024 | 0.547 | 0.205 | Aldehyde dehydrogenase inhibitor | 0.205 0.026 DBMET03426 | DBMET03426 | |
| 0.004 | 0.532 | 0.071 | Adenosine A1 receptor antagonist | 0.057 0.042 DBMET03420 0.071 0.032 DBMET03426 | DBMET03426 | |
| 0.003 | 0.532 | 0.057 | Fumarate hydratase inhibitor | 0.057 0.011 DBMET03426 | DBMET03426 | |
| 0.007 | 0.537 | 0.067 | EphB4 antagonist | 0.067 0.032 DBMET03420 | DBMET03420 | |
| 0.005 | 0.548 | 0.05 | Bruton tyrosine kinase inhibitor | 0.05 0.046 DBMET03420 | DBMET03420 | |
| 0.009 | 0.554 | 0.137 | M17 leucyl aminopeptidase inhibitor | 0.137 0.064 DBMET03426 | DBMET03426 | |
| 0.011 | 0.556 | 0.146 | Tyrosine-protein kinase receptor antagonist | 0.146 0.067 DBMET03420 | DBMET03420 | |
| 0.004 | 0.551 | 0.084 | Adenosine A2a receptor antagonist | 0.084 0.03 DBMET03420 0.062 0.043 DBMET03426 | DBMET03420 | |
| 0.058 | 0.609 | 0.422 | Cyclophilin D inhibitor | 0.244 0.22 DBMET03421 0.257 0.205 DBMET03425 0.422 0.079 DBMET03426 | DBMET03426 | |
| 0.008 | 0.56 | 0.135 | Protein kinase (CK1) inhibitor | 0.135 0.079 DBMET03420 | DBMET03420 | |
| 0.015 | 0.573 | 0.168 | Beta amyloid protein antagonist | 0.168 0.029 DBMET03420 0.117 0.07 DBMET03426 | DBMET03420 | |
| 0.003 | 0.565 | 0.067 | Glutamate (mGluR1) antagonist | 0.067 0.032 DBMET03426 | DBMET03426 | |
| 0.009 | 0.572 | 0.15 | Alcohol dehydrogenase inhibitor | 0.15 0.02 DBMET03426 | DBMET03426 | |
| 0.02 | 0.591 | 0.156 | Adenylate cyclase inhibitor | 0.156 0.041 DBMET03426 | DBMET03426 | |
| 0.01 | 0.586 | 0.065 | Phospholipase D inhibitor | 0.065 0.064 DBMET03426 | DBMET03426 | |
| 0.018 | 0.601 | 0.131 | Electrolyte absorption antagonist | 0.131 0.029 DBMET03426 | DBMET03426 | |
| 0.006 | 0.591 | 0.102 | Diacylglycerol O-acyltransferase inhibitor | 0.079 0.015 DBMET03420 0.102 0.007 DBMET03426 | DBMET03426 | |
| 0.021 | 0.607 | 0.167 | NADH dehydrogenase inhibitor | 0.167 0.014 DBMET03426 | DBMET03426 | |
| 0.009 | 0.599 | 0.119 | TRKA antagonist | 0.119 0.068 DBMET03420 | DBMET03420 | |
| 0.016 | 0.609 | 0.183 | Insulin sensitizer | 0.183 0.092 DBMET03426 | DBMET03426 | |
| 0.029 | 0.636 | 0.192 | Hexokinase inhibitor | 0.138 0.094 DBMET03420 0.192 0.04 DBMET03426 | DBMET03426 | |
| 0.014 | 0.622 | 0.1 | Glutamate dehydrogenase inhibitor | 0.1 0.031 DBMET03426 | DBMET03426 | |
| 0.004 | 0.625 | 0.05 | Aldose reductase inhibitor | 0.05 0.039 DBMET03426 | DBMET03426 | |
| 0.013 | 0.634 | 0.061 | Purinergic P2X1 antagonist | 0.061 0.041 DBMET03426 | DBMET03426 | |
| 0.004 | 0.626 | 0.069 | Argininosuccinate synthase inhibitor | 0.069 0.031 DBMET03426 | DBMET03426 | |
| 0.012 | 0.636 | 0.108 | Uric acid excretion stimulant | 0.108 0.046 DBMET03426 | DBMET03426 | |
| 0.018 | 0.647 | 0.103 | mTOR complex 2 inhibitor | 0.098 0.036 DBMET03420 0.103 0.029 DBMET03426 | DBMET03426 | |
| 0.019 | 0.649 | 0.168 | EphB2 antagonist | 0.15 0.13 DBMET03420 0.168 0.113 DBMET03426 | DBMET03426 | |
| 0.012 | 0.643 | 0.094 | UDP-glucose 4-epimerase inhibitor | 0.094 0.068 DBMET03426 | DBMET03426 | |
| 0.085 | 0.718 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.249 DBMET03420 | DBMET03420 | |
| 0.023 | 0.657 | 0.159 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.137 DBMET03426 | DBMET03426 | |
| 0.005 | 0.64 | 0.103 | Granulocyte macrophage colony stimulating factor antagonist | 0.103 0.068 DBMET03420 | DBMET03420 | |
| 0.003 | 0.642 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.026 DBMET03426 | DBMET03426 | |
| 0.014 | 0.653 | 0.32 | Platelet antagonist | 0.216 0.091 DBMET03425 0.32 0.046 DBMET03426 | DBMET03426 | |
| 0.004 | 0.643 | 0.103 | Protein kinase (CK2) inhibitor | 0.103 0.061 DBMET03426 | DBMET03426 | |
| 0.004 | 0.645 | 0.091 | Xanthine dehydrogenase inhibitor | 0.091 0.019 DBMET03426 | DBMET03426 | |
| 0.034 | 0.684 | 0.119 | Folate antagonist | 0.119 0.039 DBMET03426 | DBMET03426 | |
| 0.019 | 0.674 | 0.306 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.177 0.097 DBMET03420 0.306 0.022 DBMET03426 | DBMET03426 | |
| 0.042 | 0.698 | 0.207 | GABA C receptor rho-3 antagonist | 0.207 0.199 DBMET03426 | DBMET03426 | |
| 0.004 | 0.66 | 0.12 | Biliverdin reductase inhibitor | 0.12 0.014 DBMET03426 | DBMET03426 | |
| 0.005 | 0.669 | 0.064 | Secretase beta inhibitor | 0.064 0.062 DBMET03420 | DBMET03420 | |
| 0.011 | 0.676 | 0.218 | I kappa B kinase epsilon inhibitor | 0.218 0.057 DBMET03420 0.202 0.069 DBMET03426 | DBMET03420 | |
| 0.014 | 0.681 | 0.298 | DNA methyltransferase I inhibitor | 0.298 0.027 DBMET03426 | DBMET03426 | |
| 0.014 | 0.683 | 0.199 | Angiogenesis stimulant | 0.199 0.095 DBMET03421 | DBMET03421 | |
| 0.005 | 0.676 | 0.134 | Protein-tyrosine phosphatase 1B inhibitor | 0.134 0.053 DBMET03426 | DBMET03426 | |
| 0.016 | 0.693 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.074 DBMET03426 | DBMET03426 | |
| 0.003 | 0.686 | 0.186 | Protein kinase (CK2) alpha inhibitor | 0.186 0.028 DBMET03426 | DBMET03426 | |
| 0.013 | 0.699 | 0.179 | Xanthine oxidase inhibitor | 0.179 0.025 DBMET03426 | DBMET03426 | |
| 0.015 | 0.703 | 0.119 | Cell wall synthesis inhibitor | 0.119 0.101 DBMET03426 | DBMET03426 | |
| 0.007 | 0.696 | 0.044 | Glutamate (mGluR group III) antagonist | 0.044 0.03 DBMET03426 | DBMET03426 | |
| 0.005 | 0.702 | 0.106 | Glycogen synthase kinase-3 alpha inhibitor | 0.106 0.098 DBMET03426 | DBMET03426 | |
| 0.004 | 0.703 | 0.093 | Histidine decarboxylase inhibitor | 0.093 0.035 DBMET03426 | DBMET03426 | |
| 0.007 | 0.71 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.032 DBMET03426 | DBMET03426 | |
| 0.003 | 0.716 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.07 DBMET03420 | DBMET03420 | |
| 0.006 | 0.72 | 0.219 | Protein-tyrosine phosphatase inhibitor | 0.132 0.099 DBMET03425 0.219 0.04 DBMET03426 | DBMET03426 | |
| 0.004 | 0.727 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 DBMET03426 | DBMET03426 | |
| 0.003 | 0.726 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET03426 | DBMET03426 | |
| 0.009 | 0.738 | 0.144 | Dual specificity phosphatase 3 inhibitor | 0.144 0.101 DBMET03426 | DBMET03426 | |
| 0.008 | 0.746 | 0.141 | GABA C receptor agonist | 0.141 0.038 DBMET03426 | DBMET03426 | |
| 0.009 | 0.748 | 0.142 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.088 DBMET03420 0.124 0.112 DBMET03426 | DBMET03420 | |
| 0.013 | 0.755 | 0.081 | MAP kinase kinase 7 inhibitor | 0.081 0.043 DBMET03426 | DBMET03426 | |
| 0.003 | 0.749 | 0.039 | GABA B receptor antagonist | 0.039 0.038 DBMET03426 | DBMET03426 | |
| 0.03 | 0.782 | 0.323 | 5 Hydroxytryptamine release inhibitor | 0.323 0.141 DBMET03426 | DBMET03426 | |
| 0.003 | 0.76 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.032 DBMET03426 | DBMET03426 | |
| 0.01 | 0.772 | 0.076 | Glutamate (mGluR6) antagonist | 0.076 0.03 DBMET03426 | DBMET03426 | |
| 0.059 | 0.825 | 0.182 | Peptidyltransferase inhibitor | 0.182 0.126 DBMET03421 | DBMET03421 | |
| 0.003 | 0.792 | 0.048 | Aconitate hydratase inhibitor | 0.048 0.042 DBMET03426 | DBMET03426 | |
| 0.009 | 0.81 | 0.136 | Dual specificity phosphatase inhibitor | 0.136 0.112 DBMET03426 | DBMET03426 | |
| 0.043 | 0.86 | 0.168 | Nitric-oxide synthase stimulant | 0.168 0.158 DBMET03426 | DBMET03426 | |
| 0.035 | 0.854 | 0.171 | Heat shock protein 70 antagonist | 0.171 0.017 DBMET03426 | DBMET03426 | |
| 0.008 | 0.827 | 0.154 | Succinate dehydrogenase inhibitor | 0.154 0.105 DBMET03426 | DBMET03426 | |
| 0.006 | 0.828 | 0.14 | Arachidonic acid antagonist | 0.14 0.1 DBMET03426 | DBMET03426 | |
| 0.005 | 0.828 | 0.077 | Myeloperoxidase inhibitor | 0.077 0.073 DBMET03426 | DBMET03426 | |
| 0.006 | 0.843 | 0.11 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.089 DBMET03426 | DBMET03426 | |
| 0.014 | 0.858 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.096 DBMET03426 | DBMET03426 | |
| 0.007 | 0.857 | 0.097 | DOPA decarboxylase inhibitor | 0.097 0.082 DBMET03426 | DBMET03426 | |
| 0.003 | 0.867 | 0.138 | Expectorant | 0.138 0.04 DBMET03426 | DBMET03426 | |
| 0.006 | 0.883 | 0.215 | DNA synthesis inhibitor | 0.215 0.101 DBMET03426 | DBMET03426 | |
| 0.003 | 0.883 | 0.058 | Selectin antagonist | 0.058 0.051 DBMET03421 | DBMET03421 | |
| 0.003 | 0.896 | 0.106 | Mucolytic | 0.106 0.069 DBMET03426 | DBMET03426 | |
| 0.005 | 0.905 | 0.18 | Thrombolytic | 0.18 0.062 DBMET03426 | DBMET03426 | |
| 0.002 | 0.949 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.072 DBMET03426 | DBMET03426 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |